Jenoptik Reports Double-Digit Revenue Growth Amid Semiconductor Surge

Jenoptik AG reported a significant uptick in its financial performance for the first nine months of 2026, highlighted by double-digit revenue growth in the most recent quarter. The technology group attributed much of this momentum to a faster-than-expected recovery in the semiconductor industry, which drove substantial order intake in its original equipment manufacturer (OEM) business.

According to CEO Dominic Dorfner, the semiconductor sector's ramp-up is currently in full swing, providing a tailwind that surpassed the company's initial projections. This demand was complemented by continued growth in the biophotonics division, which managed to increase its order volume even when compared to the high performance levels recorded in the previous year.

Financial Highlights and Profitability

The company also saw a notable rise in profitability during this period. Management noted that the EBITDA margin exceeded expectations, driven by several key factors:

• A rapid production ramp-up within the semiconductor segment.
• A favorable shift in the overall product mix toward higher-margin components.
• Strong order intake momentum in the OEM business exceeding internal forecasts.

The surge in high-tech manufacturing orders suggests a robust environment for specialized optical and electronic components. While the semiconductor market remains a primary driver, the steady performance of the biophotonics unit indicates diversified demand across healthcare and life sciences applications.

What to watch next: Market participants will be monitoring if the current pace of semiconductor equipment orders can be sustained through the end of the fiscal year and how the company manages operational scaling during this high-growth phase.